- Home
- ATCH vs SXTP Comparison
ATCH vs SXTP Comparison
Compare ATCH & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATCH
- SXTP
- Stock Information
- Founded
- ATCH 2022
- SXTP 2010
- Country
- ATCH United States
- SXTP United States
- Employees
- ATCH N/A
- SXTP N/A
- Industry
- ATCH
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- ATCH
- SXTP Health Care
- Exchange
- ATCH Nasdaq
- SXTP Nasdaq
- Market Cap
- ATCH 3.0M
- SXTP 3.4M
- IPO Year
- ATCH N/A
- SXTP 2023
- Fundamental
- Price
- ATCH $0.21
- SXTP $2.61
- Analyst Decision
- ATCH
- SXTP Buy
- Analyst Count
- ATCH 0
- SXTP 2
- Target Price
- ATCH N/A
- SXTP $7.00
- AVG Volume (30 Days)
- ATCH 1.7M
- SXTP 94.2K
- Earning Date
- ATCH 08-27-2025
- SXTP 08-13-2025
- Dividend Yield
- ATCH N/A
- SXTP N/A
- EPS Growth
- ATCH N/A
- SXTP N/A
- EPS
- ATCH 2.67
- SXTP N/A
- Revenue
- ATCH N/A
- SXTP $802,323.00
- Revenue This Year
- ATCH N/A
- SXTP $95.50
- Revenue Next Year
- ATCH N/A
- SXTP $80.78
- P/E Ratio
- ATCH $0.08
- SXTP N/A
- Revenue Growth
- ATCH N/A
- SXTP 118.37
- 52 Week Low
- ATCH $0.18
- SXTP $1.41
- 52 Week High
- ATCH $61.20
- SXTP $35.99
- Technical
- Relative Strength Index (RSI)
- ATCH 44.83
- SXTP 56.64
- Support Level
- ATCH $0.18
- SXTP $2.20
- Resistance Level
- ATCH $0.22
- SXTP $2.43
- Average True Range (ATR)
- ATCH 0.01
- SXTP 0.19
- MACD
- ATCH 0.01
- SXTP 0.03
- Stochastic Oscillator
- ATCH 77.84
- SXTP 90.91
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.